Navigation Links
Zebrafish discovery may shed light on human kidney function

ROCHESTER, Minn. Feb. 20, 2014 Researchers say the discovery of how sodium ions pass through the gill of a zebrafish may be a clue to understanding a key function in the human kidney. The findings from a collaboration between Mayo Clinic and the Tokyo Institute of Technology appear in the online issue of the American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.

The researchers discovered a protein responsible for gas exchanges in the fish gill structure. Specifically they studied and characterized the Na+/H+ (sodium/hydrogen) exchanger named NHE3, responsible for controlling sodium and hydrogen ions across the gill. The researchers also directly demonstrated that NHE3 can function as a Na+/NH4+ (sodium/ammonium) exchanger.

"This is significant because the fish tends to mimic the process in humans," says Michael Romero, Ph.D., a Mayo Clinic physiologist who works in nephrology. "This is the true beauty of comparative physiology- a lot of the organs function by very similar processes, down to ionic transfer."

In this case the protein allows the sodium ions to be absorbed from the forming urine while at the same time discarding waste from normally functioning cells, thus keeping the body in balance and serving as an energy saving system. The researchers say the same NHE3 protein performs a similar function in the intestine, pancreas, liver, lungs and reproductive system.

The gill is used in the fish as a transport system: sodium ions are nutrients and ammonium carries away waste. It's a key process allowing zebrafish to extract sodium ions from fresh water. In humans, NHE3 is involved in the acid-waste control system in the kidney, but there hasn't been a good analysis of that process in humans. Part of this acid-control process in the human kidney is "ammoniagenesis" which requires the initial part of the kidney tubule (proximal tubule) to export ammonia/ammonium. Physiologically, it has been assumed that NHE3 can perform a Na+/NH4+ exchange, but this has never been experimentally demonstrated.

Ammoniagenesis and increased renal sodium bicarbonate absorption are partly under the control of the renin-angiotensin-aldosterone system (RAAS), which means that this work enhances understanding of human hypertension. Researchers say their results in fish can be a clue or starting point for analyzing the process in people. Researchers say they hope to continue their work in other species and ultimately further describe the process in humans.


Contact: Bob Nellis
Mayo Clinic

Related medicine news :

1. For first time, drug developed based on zebrafish studies passes Phase I clinical trial
2. Family ties: Relationship between human and zebrafish genomes
3. The zebrafish revealed a central regulator for the development of the brain histamine system
4. Individual gene differences can be tested in zebrafish
5. Tension on gut muscles induces cell invasion in zebrafish intestine, mimicking cancer metastasis
6. Zebrafish reveal promising mechanism for healing spinal cord injury
7. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
8. NUS researchers make new discovery of protein as a promising target for treatment of ATC
9. Drug discovery potential of natural microbial genomes
10. Prion discovery could help keep deadly brain diseases in check
11. Autism Learning Games: Camp Discovery App Utilizes Technology to Revolutionize Learning for Children with Autism
Post Your Comments:
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
Breaking Medicine Technology: